[Pyruvate kinase, 2,3 bisphosphoglycerate and fibrin-fibrinogen degradation products in patients with polycythemia, before and after erythrapheresis therapy].
Buchtová
L
L
Hrubesová
J
J
Krácmar
C
C
D019794:2,3-Diphosphoglycerate; D001781:Blood Component Removal; D004163:Diphosphoglyceric Acids / Q000097:blood*; D017707:Erythrocyte Transfusion; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000097:blood* / Q000628:therapy; D011770:Pyruvate Kinase / Q000097:blood*
D004163:Diphosphoglyceric Acids; D005338:Fibrin Fibrinogen Degradation Products; D019794:2,3-Diphosphoglycerate; D011770:Pyruvate Kinase
Pyruvátkináza, 2,3 bifosfoglycerát a fibrin-fibrinogen degradacní produkty u nemocných s polycytémií, pred a po lécebné erytraferéze.